A three-component biomarker panel for prediction of dengue hemorrhagic fever.

Authors:
Address: Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA. arbrasie@utmb.edu
Journal:


Publication:

abstract

dengue virus infections are a major cause of morbidity in tropical countries. Early detection of dengue hemorrhagic fever (DHF) may help identify individuals that would benefit from intensive therapy. Predictive modeling was performed using 11 laboratory values of 51 individuals (38 DF and 13 DHF) obtained on initial presentation using logistic regression. We produced a robust model with an area under the curve of 0.9615 that retained IL-10 levels, platelets, and lymphocytes as the major predictive features. A classification and regression tree was developed on these features that were 86% accurate on cross-validation. The IL-10 levels and platelet counts were also identified as the most informative features associated with DHF using a Random Forest classifier. In the presence of polymerase chain reaction-proven acute dengue infections, we suggest a complete blood count and rapid measurement of IL-10 can assist in the triage of potential DHF cases for close follow-up or clinical intervention improving clinical outcome.



Related Articles
Activation of endothelial cells, coagulation and fibrinolysis in children with Dengue virus infection.
Thromb Haemost. 2007
Activation of endothelial cells, coagulation and fibrinolysis in children with Dengue virus infection.
Sosothikul D, Seksarn P, Pongsewalak S, Thisyakorn U, Lusher J. Thromb Haemost. 2007 Apr; 97(4):627-34.
Haematological and biochemical indicators for the early diagnosis of dengue viral infection.
J Coll Physicians Surg Pak. 2008
Haematological and biochemical indicators for the early diagnosis of dengue viral infection.
Butt N, Abbassi A, Munir SM, Ahmad SM, Sheikh QH. J Coll Physicians Surg Pak. 2008 May; 18(5):282-5.
Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response.
J Infect Dis. 2008
Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response.
Guilarde AO, Turchi MD, Siqueira JB Jr, Feres VC, Rocha B, Levi JE, Souza VA, Boas LS, Pannuti CS, Martelli CM. J Infect Dis. 2008 Mar 15; 197(6):817-24.
Review Clinical and laboratory features that distinguish dengue from other febrile illnesses in endemic populations.
Trop Med Int Health. 2008
Review Clinical and laboratory features that distinguish dengue from other febrile illnesses in endemic populations.
Potts JA, Rothman AL. Trop Med Int Health. 2008 Nov; 13(11):1328-40. Epub 2008 Sep 16.
Review Dengue hemorrhagic fever: clinical manifestations and management.
Indian J Pediatr. 1999
Review Dengue hemorrhagic fever: clinical manifestations and management.
Kabra SK, Jain Y, Singhal T, Ratageri VH. Indian J Pediatr. 1999 Jan-Feb; 66(1):93-101.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.